Jasper Therapeutics Inc
Change company Symbol lookup
Select an option...
JSPR Jasper Therapeutics Inc
GEO Geo Group Inc
SAIC Science Applications International Corp
MUR Murphy Oil Corp
SPHD Invesco S&P 500® High Dividend Low Volatility ETF
CODI Compass Diversified Holdings
MDRRP Medalist Diversified Reit Inc
BRKL Brookline Bancorp Inc
KBH KB Home
UPS United Parcel Service Inc
Go

Company profile

Jasper Therapeutics, Inc., formerly Amplitude Healthcare Acquisition Corporation, is a biotechnology company focused on hematopoietic cell transplant therapies. The Company has developed programs, such as JSP191, an anti-CD117 monoclonal antibody, which is in clinical development as a conditioning agent that clears hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It is designed to enable curative allogeneic and autologous hematopoietic cell transplants and gene therapies. The Company also provides a preclinical engineered hematopoietic stem cell (eHSC) platform, which is designed to overcome limitations of allogeneic and autologous gene-edited stem cell grafts. Its programs are used to cure and expand hematopoietic stem cell therapy to cure patients with life-threatening cancers, thalassemia, sickle cell diseases, genetic diseases and autoimmune diseases.

Closing Price
$4.36
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.66
Day's Low
4.25
Volume
(Light)
Volume:
51,421

10-day average volume:
92,762
51,421

Display:

Providers:

UpdateCancel
6 providers
December 08, 2021
Jasper Therapeutics to Present Data on JSP191 Conditioning in SCID patients at the 2021 American Society of Hematology Annual Meeting

-- Single-agent conditioning with JSP191 is associated with engraftment, immune reconstitution, and clinical benefit Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic cell transplant therapies, today...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.